{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:16:38Z","timestamp":1790982998251,"version":"4.1.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,23]]},"DOI":"10.7759\/cureus.113256","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:36:39Z","timestamp":1784864199000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Rosuvastatin-Associated Myopathy With Persistent HyperCKemia and Transaminitis: Early Outpatient Recognition and Diagnostic Pitfalls"],"prefix":"10.7759","author":[{"given":"Hussain Ahmad","family":"Bhatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson PD","year":"2003","unstructured":"Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. 2003, 289:1681-90. 10.1001\/jama.289.13.1681","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on assessment, aetiology and management","volume":"36","author":"Stroes ES","year":"2015","unstructured":"Stroes ES, Thompson PD, Corsini A, et al.. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on assessment, aetiology and management. Eur Heart J. 2015, 36:1012-22. 10.1093\/eurheartj\/ehv043","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1515161","article-title":"Statin-associated autoimmune myopathy","volume":"374","author":"Mammen AL","year":"2016","unstructured":"Mammen AL. Statin-associated autoimmune myopathy. N Engl J Med. 2016, 374:664-9. 10.1056\/NEJMra1515161","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach Y","year":"2020","unstructured":"Allenbach Y, Benveniste O, Stenzel W, Boyer O. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol. 2020, 16:689-701. 10.1038\/s41584-020-00515-9","journal-title":"Nat Rev Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103468","article-title":"Anti-HMGCR immune-mediated necrotising myopathy: addressing the remaining issues","volume":"22","author":"Khoo T","year":"2023","unstructured":"Khoo T, Chinoy H. Anti-HMGCR immune-mediated necrotising myopathy: addressing the remaining issues. Autoimmun Rev. 2023, 22:103468. 10.1016\/j.autrev.2023.103468","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1440206","article-title":"Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations","volume":"14","author":"Selva-O'Callaghan A","year":"2018","unstructured":"Selva-O'Callaghan A, Alvarado-Cardenas M, Pinal-Fern\u00e1ndez I, et al.. Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations. Expert Rev Clin Immunol. 2018, 14:215-24. 10.1080\/1744666X.2018.1440206","journal-title":"Expert Rev Clin Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2014.03.004","article-title":"An assessment by the Statin Muscle Safety Task Force: 2014 update","volume":"8","author":"Rosenson RS","year":"2014","unstructured":"Rosenson RS, Baker SK, Jacobson TA, Kopecky SL, Parker BA. An assessment by the Statin Muscle Safety Task Force: 2014 update. J Clin Lipidol. 2014, 8:S58-71. 10.1016\/j.jacl.2014.03.004","journal-title":"J Clin Lipidol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/513309-severe-rosuvastatin-associated-myopathy-with-persistent-hyperckemia-and-transaminitis-early-outpatient-recognition-and-diagnostic-pitfalls","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:36:42Z","timestamp":1784864202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/513309-severe-rosuvastatin-associated-myopathy-with-persistent-hyperckemia-and-transaminitis-early-outpatient-recognition-and-diagnostic-pitfalls"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.113256","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}